NCT00577460View on ClinicalTrials.gov

Long-term Safety Study of Open-label Pramipexole ER in Patients With Advanced PD

PHASE3CompletedINTERVENTIONAL
Enrollment

391

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

June 30, 2010

Conditions
Parkinson Disease
Interventions
DRUG

Pramipexole

Pramipexole ER 0.375 -4.5 mg

DRUG

Placebo

Placebo tablets identical to Pramipexole ER tablets

Trial Locations (70)

Unknown

248.634.43005 Boehringer Ingelheim Investigational Site, Linz

248.634.42003 Boehringer Ingelheim Investigational Site, Pardubice

248.634.42001 Boehringer Ingelheim Investigational Site, Prague

248.634.42005 Boehringer Ingelheim Investigational Site, Rakovník

248.634.42002 Boehringer Ingelheim Investigational Site, Rychnov nad Kněžnou

248.634.42004 Boehringer Ingelheim Investigational Site, Valašské Meziříčí

248.634.36005 Boehringer Ingelheim Investigational Site, Győr

248.634.36003 Boehringer Ingelheim Investigational Site, Kecskemét

248.634.36006 Boehringer Ingelheim Investigational Site, Szeged

248.634.36004 Boehringer Ingelheim Investigational Site, Veszprém

248.634.91002 Boehringer Ingelheim Investigational Site, Chennai

248.634.91001 Boehringer Ingelheim Investigational Site, Delhi

248.634.91003 Boehringer Ingelheim Investigational Site, Hyderabad

248.634.91007 Boehringer Ingelheim Investigational Site, Indore

248.634.91005 Boehringer Ingelheim Investigational Site, Karnataka

248.634.91006 Boehringer Ingelheim Investigational Site, Pune

248.634.39001 Boehringer Ingelheim Investigational Site, Catania

248.634.39010 Boehringer Ingelheim Investigational Site, Catanzaro

248.634.39009 Boehringer Ingelheim Investigational Site, Chieti

248.634.39007 Boehringer Ingelheim Investigational Site, Grosseto

248.634.39002 Boehringer Ingelheim Investigational Site, Napolii

248.634.39008 Boehringer Ingelheim Investigational Site, Pisa

248.634.39005 Boehringer Ingelheim Investigational Site, Roma

248.634.39011 Boehringer Ingelheim Investigational Site, Roma

248.634.63202 Boehringer Ingelheim Investigational Site, Cruz, Manila

248.634.63207 Boehringer Ingelheim Investigational Site, Ermita, Manila

248.634.63210 Boehringer Ingelheim Investigational Site, Makati City

248.634.63205 Boehringer Ingelheim Investigational Site, Manila

248.634.63206 Boehringer Ingelheim Investigational Site, Manila

248.634.63201 Boehringer Ingelheim Investigational Site, Pasig

248.634.63208 Boehringer Ingelheim Investigational Site, Quezon

248.634.63204 Boehringer Ingelheim Investigational Site, Quezon City

248.634.48001 Boehringer Ingelheim Investigational Site, Gdansk

248.634.48003 Boehringer Ingelheim Investigational Site, Krakow

248.634.48002 Boehringer Ingelheim Investigational Site, Warsaw

248.634.07001 Boehringer Ingelheim Investigational Site, Moscow

248.634.07002 Boehringer Ingelheim Investigational Site, Moscow

248.634.07003 Boehringer Ingelheim Investigational Site, Moscow

248.634.07004 Boehringer Ingelheim Investigational Site, Moscow

248.634.07007 Boehringer Ingelheim Investigational Site, Moscow

248.634.07006 Boehringer Ingelheim Investigational Site, Saint Petersburg

248.634.42104 Boehringer Ingelheim Investigational Site, Bratislava

248.634.42105 Boehringer Ingelheim Investigational Site, Bratislava

248.634.42103 Boehringer Ingelheim Investigational Site, Dubnica nad Váhom

248.634.42101 Boehringer Ingelheim Investigational Site, Trnava

248.634.82001 Boehringer Ingelheim Investigational Site, Gyeonggi-do

248.634.82008 Boehringer Ingelheim Investigational Site, Kyeonggi-do

248.634.82007 Boehringer Ingelheim Investigational Site, Pusan

248.634.82002 Boehringer Ingelheim Investigational Site, Seoul

248.634.82003 Boehringer Ingelheim Investigational Site, Seoul

248.634.82004 Boehringer Ingelheim Investigational Site, Seoul

248.634.82005 Boehringer Ingelheim Investigational Site, Seoul

248.634.82006 Boehringer Ingelheim Investigational Site, Seoul

248.634.34001 Boehringer Ingelheim Investigational Site, Alcorcon (Madrid)

248.634.34003 Boehringer Ingelheim Investigational Site, Barcelona

248.634.34004 Boehringer Ingelheim Investigational Site, Barcelona

248.634.34005 Boehringer Ingelheim Investigational Site, Madrid

248.634.34002 Boehringer Ingelheim Investigational Site, San Cugat Del Valles (Barcelona)

248.634.34008 Boehringer Ingelheim Investigational Site, Tarrasa (Barcelona)

248.634.46005 Boehringer Ingelheim Investigational Site, Malmo

248.634.46002 Boehringer Ingelheim Investigational Site, Nyköping

248.634.46001 Boehringer Ingelheim Investigational Site, Stockholm

248.634.38003 Boehringer Ingelheim Investigational Site, Dnipropetrovsk

248.634.38006 Boehringer Ingelheim Investigational Site, Kharkiv

248.634.38002 Boehringer Ingelheim Investigational Site, Kiev

248.634.38004 Boehringer Ingelheim Investigational Site, Kiev

248.634.38001 Boehringer Ingelheim Investigational Site, Zaporizhzhya

248.634.38005 Boehringer Ingelheim Investigational Site, Zaporizhzhya

248.634.44007 Boehringer Ingelheim Investigational Site, Blackburn

248.634.44003 Boehringer Ingelheim Investigational Site, Salford

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY